与淋巴结转移和T2结肠癌中生存率相关的因素
Shaojun Liu1, Lei Hu1, Xubing Zhang2
1Department of Colorectal Surgery, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, Anhui, China.
BMC gastroenterology
|March 15, 2025
概括
淋巴血管侵入和淋巴结异质性是T2结肠癌中淋巴结转移的关键指标. 识别这些因素可以指导手术决策,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术病理学手术病理学
背景情况:
- T2结肠癌呈现临界阶段,有可能发生淋巴结转移 (LNM).
- 了解预测LNM和生存的临床因素对于治疗规划至关重要.
研究的目的:
- 为了确定与T2结肠癌中淋巴结转移 (LNM) 相关的临床因素.
- 探索T2结肠癌患者的生存预测因素.
主要方法:
- 对150名T2结肠癌患者进行了彻底手术 (2017-2021) 的回顾性分析.
- 使用后勤和考克斯回归分析来确定LNM和生存的风险因素.
- 数据包括人口统计,放射学,病理学和生存信息.
主要成果:
- 淋巴血管侵袭 (LVI) 和淋巴结异质性是LNM的独立风险因素.
- 患有LNM的患者的无病存活率 (DFS) 显著降低 (80%与93.3%相比).
- 较高的CA199水平和LNM与较差的整体存活率 (OS) 和DFS相关.
结论:
- 淋巴结异质和淋巴结异质是T2结肠癌中LNM的重要独立风险因素.
- 当这些危险因素存在时,建议考虑更广泛的手术.
- 这些发现有助于风险分层和T2结肠癌的个性化治疗策略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


